ABSTRACT SUBMISSION

Abstract submissions are invited for the following:

• Oral Presentation – please note that there are a limited number of positions available for Oral Presentations. These will be selected by the Scientific Committee.

• Poster Presentation – these will be displayed for the duration of the meeting with an allocated time for the presenting author to be available for questions. Posters are to be AO poster size.

Program Themes:

• Acute Lymphoblastic Leukaemia
• Chronic Lymphocytic Leukaemia
• Acute Myeloid Leukaemia
• Myelodysplasic syndrome
• Lymphoma
• Metabolism
• Myeloma
• Myeloproliferative neoplasms including Chronic Myeloid Leukaemia
• Immunotherapy
• Cell Therapy
• Genomics
• Epigenetics
• Stem Cells and Microenvironment
• New Therapeutic Approaches 

Abstract Submission Instructions:

Please read through the submission instructions listed below before preparing your abstract:

Step 1: Write your abstract following the Abstract Requirements and Guidelines.
Step 2: Click on the below SUBMIT HERE button to complete the Abstract Submission and follow the prompts.

NOW CLOSED

Authors will be notified of their abstract submission status: expected early December 2023.

Presentation Format:

The Scientific Committee reserves the right to decide the format of presentation on the basis of time and space available.

Please note:

All presenters must be registered for the Meeting, and are responsible for their own registration fees, personal travel and accommodation expenses.

The Meeting Managers will not be held responsible for abstract submissions not received via the website or for submission errors caused by internet service outages, hardware or software delays, power outages or unforeseen events.